Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (29)
Xiaoli Ren, Xiaoyong Liu, Miao Hua, Yan Dai, Xiaoping Ren, Chaoya Sui, Xiangbi Li, Zhiyong Jiang, Min Tian & Bing Yang. (2023) Discovery a series of novel inhibitors of human dihydroorotate dehydrogenase: Biological activity evaluation and molecular docking. Chemical Biology & Drug Design.
Crossref
Crossref
Anna Luganini, Giulia Sibille, Marta Pavan, Maurizia Mello Grand, Stefano Sainas, Donatella Boschi, Marco L. Lolli, Giovanna Chiorino & Giorgio Gribaudo. (2023) Mechanisms of antiviral activity of the new hDHODH inhibitor MEDS433 against respiratory syncytial virus replication. Antiviral Research 219, pages 105734.
Crossref
Crossref
Douglas Fraser-Pitt, Derry K. Mercer, Marie-Louise Francis, David Toledo-Aparicio, Daniel W. Smith & Deborah A. O'Neil. (2023) Cysteamine-mediated blockade of the glycine cleavage system modulates epithelial cell inflammatory and innate immune responses to viral infection. Biochemical and Biophysical Research Communications 677, pages 168-181.
Crossref
Crossref
A. N. Arevefa, A. R. Dorotenko, S. M. Noskov, I. E. Makarenko, R. V. Drai, T. N. Komarov, O. A. Archakova, N. S. Bagaeva & I. E. Shokhin. (2023) An Open-label Randomized Crossover Study with Adaptive Design of the Pharmacokinetics and Bioequivalence of GP30121 and Ceraxon® Corrected for Endogenous Analyte Level. Drug development & registration 12:3, pages 218-227.
Crossref
Crossref
Alvan Amos, Alex Amos, Lirong Wu & He Xia. (2023) The Warburg effect modulates DHODH role in ferroptosis: a review. Cell Communication and Signaling 21:1.
Crossref
Crossref
Mengying Jiang, Yizuo Song, Hejing Liu, Yanshan Jin, Ruyi Li & Xueqiong Zhu. (2023) DHODH Inhibition Exerts Synergistic Therapeutic Effect with Cisplatin to Induce Ferroptosis in Cervical Cancer through Regulating mTOR Pathway. Cancers 15:2, pages 546.
Crossref
Crossref
Sean H. Colligan, Andrea M. Amitrano, Robert A. Zollo, Jennifer Peresie, Elliot D. Kramer, Brian Morreale, Joseph Barbi, Prashant K. Singh, Han Yu, Jianmin Wang, Mateusz Opyrchal, David B. Sykes, Michael J. Nemeth & Scott I. Abrams. (2022) Inhibiting the biogenesis of myeloid-derived suppressor cells enhances immunotherapy efficacy against mammary tumor progression. Journal of Clinical Investigation 132:23.
Crossref
Crossref
Chungen Li, Yue Zhou, Jing Xu, Xia Zhou, Song Liu, Zongkai Huang, Zhiqiang Qiu, Ting Zeng, Kun Gou, Lei Tao, Xi Zhong, Xiaowei Yang, Yang Zhou, Na Su, Qiang Chen, Yinglan Zhao & Youfu Luo. (2022) Discovery of potent human dihydroorotate dehydrogenase inhibitors based on a benzophenone scaffold. European Journal of Medicinal Chemistry 243, pages 114737.
Crossref
Crossref
Twana Alkasalias, Juan Zhang, Harsha Madapura, Basile Dalarun, Oscar Bedoya Reina, Rolf Lewensohn, Kristina Viktorsson, Abbas Salihi, Suhas Darekar & Sonia Laín. (2022) Proof-of-principle studies on a strategy to enhance nucleotide imbalance specifically in cancer cells. Cell Death Discovery 8:1.
Crossref
Crossref
Rishi Banerjee, Janne Purhonen & Jukka Kallijärvi. (2021) The mitochondrial coenzyme Q junction and complex III: biochemistry and pathophysiology. The FEBS Journal 289:22, pages 6936-6958.
Crossref
Crossref
Giulia Sibille, Anna Luganini, Stefano Sainas, Donatella Boschi, Marco Lucio Lolli & Giorgio Gribaudo. (2022) The Novel hDHODH Inhibitor MEDS433 Prevents Influenza Virus Replication by Blocking Pyrimidine Biosynthesis. Viruses 14:10, pages 2281.
Crossref
Crossref
Stefano Sainas, Marta Giorgis, Paola Circosta, Giulio Poli, Marta Alberti, Alice Passoni, Valentina Gaidano, Agnese C. Pippione, Nicoletta Vitale, Davide Bonanni, Barbara Rolando, Alessandro Cignetti, Cristina Ramondetti, Alessia Lanno, Davide M. Ferraris, Barbara Canepa, Barbara Buccinnà, Marco Piccinini, Menico Rizzi, Giuseppe Saglio, Salam Al-Karadaghi, Donatella Boschi, Riccardo Miggiano, Tiziano Tuccinardi & Marco L. Lolli. (2022)
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-
a
]pyridine Scaffold: SAR of the Aryloxyaryl Moiety
. Journal of Medicinal Chemistry 65:19, pages 12701-12724.
Crossref
Crossref
Justin S. Cisar, Christine Pietsch, Lindsey G. DeRatt, Edgar Jacoby, Faraz Kazmi, Colleen Keohane, Katie Legenski, Rosalie Matico, Paul Shaffer, Yvan Simonnet, Alexandra Tanner, Chao-Yuan Wang, Weixue Wang, Ricardo Attar, James P. Edwards & Scott D. Kuduk. (2022)
N
-Heterocyclic 3-Pyridyl Carboxamide Inhibitors of DHODH for the Treatment of Acute Myelogenous Leukemia
. Journal of Medicinal Chemistry 65:16, pages 11241-11256.
Crossref
Crossref
Chungen Li, Yue Zhou, Jing Xu, Xia Zhou, Zongkai Huang, Ting Zeng, Xiaowei Yang, Lei Tao, Kun Gou, Xi Zhong, Qiang Chen, Youfu Luo & Yinglan Zhao. (2022) A novel series of teriflunomide derivatives as orally active inhibitors of human dihydroorotate dehydrogenase for the treatment of colorectal carcinoma. European Journal of Medicinal Chemistry 238, pages 114489.
Crossref
Crossref
Saad Saeed Alqahtani, Tomas Koltai, Muntaser E. Ibrahim, Adil H. H. Bashir, Sari T. S. Alhoufie, Samrein B. M. Ahmed, Daria Di Molfetta, Tiago M. A. Carvalho, Rosa Angela Cardone, Stephan Joel Reshkin, Abdelhameed Hifny, Mohamed E. Ahmed & Khalid Omer Alfarouk. (2022) Role of pH in Regulating Cancer Pyrimidine Synthesis. Journal of Xenobiotics 12:3, pages 158-180.
Crossref
Crossref
Xiaowei Yang, Chungen Li, Kun Gou, Xiaocong Liu, Yue Zhou, Jiao Zou, Qiang Chen, Youfu Luo & Yinglan Zhao. (2022) A novel and potent dihydroorotate dehydrogenase inhibitor suppresses the proliferation of colorectal cancer by inducing mitochondrial dysfunction and DNA damage. MedComm – Oncology 1:1.
Crossref
Crossref
Lele Zhang, Jifa Zhang, Jiaxing Wang, Changyu Ren, Pan Tang, Liang Ouyang & Yuxi Wang. (2022) Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer therapy: Current development and future perspectives. European Journal of Medicinal Chemistry 232, pages 114176.
Crossref
Crossref
Noha Samir Taibe, Maimona A. Kord, Mohamed Ahmed Badawy, Iart Luca Shytaj & Mahmoud M. Elhefnawi. (2022) Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment. Therapeutic Advances in Respiratory Disease 16, pages 175346662211327.
Crossref
Crossref
Andreas Krämer, Amelie Tjaden, Benardina Ndreshkjana, Claudia Tredup, Henner F. Farin, Stefan Knapp, Yves L. Janin & Susanne Müller. (2022) IPP/CNRS-A017: A chemical probe for human dihydroorotate dehydrogenase (hDHODH). Current Research in Chemical Biology 2, pages 100034.
Crossref
Crossref
Arianna Calistri, Anna Luganini, Barbara Mognetti, Elizabeth Elder, Giulia Sibille, Valeria Conciatori, Claudia Del Vecchio, Stefano Sainas, Donatella Boschi, Nuria Montserrat, Ali Mirazimi, Marco Lucio Lolli, Giorgio Gribaudo & Cristina Parolin. (2021) The New Generation hDHODH Inhibitor MEDS433 Hinders the In Vitro Replication of SARS-CoV-2 and Other Human Coronaviruses. Microorganisms 9:8, pages 1731.
Crossref
Crossref
Thomas Schneider, Maximilian Fleischmann, Daniel Hergesell, Nicola Majstorović & Gerhard Maas. (2021)
A Convenient Synthesis of 4‐CF
3
‐Quinolines from 1‐Trifluoromethyl‐prop‐2‐yne 1‐Iminium Salts and Arylamines
. European Journal of Organic Chemistry 2021:20, pages 2869-2886.
Crossref
Crossref
Anna Luganini, Giulia Sibille, Barbara Mognetti, Stefano Sainas, Agnese Chiara Pippione, Marta Giorgis, Donatella Boschi, Marco L. Lolli & Giorgio Gribaudo. (2021) Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication. Antiviral Research 189, pages 105057.
Crossref
Crossref
Rui Jin, Boxuan Liu, Xiuju Liu, Yijian Fan, Wei Peng, Chunzi Huang, Adam Marcus, Gabriel Sica, Melissa Gilbert-Ross, Yuan Liu & Wei Zhou. (2021) Leflunomide Suppresses the Growth of LKB1-Inactivated Tumors in the Immune-Competent Host and Attenuates Distant Cancer Metastasis. Molecular Cancer Therapeutics 20:2, pages 274-283.
Crossref
Crossref
Mohamad F.A. Kadir, Shatrah Othman & Kavitha Nellore. (2020) Dihydroorotate Dehydrogenase Inhibitors Promote Cell Cycle Arrest and Disrupt Mitochondria Bioenergetics in Ramos Cells. Current Pharmaceutical Biotechnology 21:15, pages 1654-1665.
Crossref
Crossref
Gabrielle McDonald, Victor Chubukov, John Coco, Kevin Truskowski, Rohini Narayanaswamy, Sung Choe, Mya Steadman, Erin Artin, Anil K. Padyana, Lei Jin, Sebastien Ronseaux, Charles Locuson, Zi-Peng Fan, Tabea Erdmann, Alan Mann, Sebastian Hayes, Mark Fletcher, Kavitha Nellore, Siva Sanjeeva Rao, Hosahalli Subramanya, K. Satish Reddy, Sunil K. Panigrahi, Thomas Antony, Sreevalsam Gopinath, Zhihua Sui, Nelamangala Nagaraja, Lenny Dang, Georg Lenz, Jonathan Hurov, Scott A. Biller, Josh Murtie, Kevin M. Marks & Danielle B. Ulanet. (2020) Selective Vulnerability to Pyrimidine Starvation in Hematologic Malignancies Revealed by AG-636, a Novel Clinical-Stage Inhibitor of Dihydroorotate Dehydrogenase. Molecular Cancer Therapeutics 19:12, pages 2502-2515.
Crossref
Crossref
Rami A. Al-Horani & Srabani Kar. (2020) Potential Anti-SARS-CoV-2 Therapeutics That Target the Post-Entry Stages of the Viral Life Cycle: A Comprehensive Review. Viruses 12:10, pages 1092.
Crossref
Crossref
Yu-Jin Kim, Beatrice Cubitt, Yingyun Cai, Jens H. Kuhn, Daniel Vitt, Hella Kohlhof & Juan C. de la Torre. (2020) Novel Dihydroorotate Dehydrogenase Inhibitors with Potent Interferon-Independent Antiviral Activity against Mammarenaviruses In Vitro. Viruses 12:8, pages 821.
Crossref
Crossref
Johanna Huchting. (2020) Targeting viral genome synthesis as broad-spectrum approach against RNA virus infections. Antiviral Chemistry and Chemotherapy 28, pages 204020662097678.
Crossref
Crossref
Lucille Stuani, Marie Sabatier & Jean-Emmanuel Sarry. (2019) Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia. BMC Biology 17:1.
Crossref
Crossref